Red blood cell utilization in patients with sickle cell disease: A Canadian single‐center experience
Transfusion · 2025
DOI: 10.1111/trf.18103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Kelsey Uminski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Canadian Hematology Society.
Abstract (Originalsprache)
Background
Red blood cell (RBC) utilization in patients with sickle cell disease (SCD) in Canada is poorly defined. This study describes RBC utilization in an SCD cohort at a single Canadian center. Study Design and Methods All adults with SCD who received care at the Ottawa Hospital between January 2006 and May 2019 were included, and followed until December 2021. Data on hospital encounters and RBC transfusions were obtained from hospital databases.
Results
Overall, 273 patients were included (median age: 25 years; 53.8% female; median follow‐up: 8.1 years). During the study period, there were 23,127 hospital encounters (median: 45 [interquartile range (IQR) 18, 100] per patient), with 165 patients (60.4% of cohort) receiving 22,538 RBC units. Most RBC units (86.5%) were transfused in the outpatient setting. Although only 2.9% of patients had O‐negative blood type, O‐negative RBC units accounted for 29.1% of units transfused. One hundred forty‐seven patients received 2205 RBC units (9.8% of total) as simple transfusions (median: 5 [IQR 3, 13] per patient), and 88 patients received 20,333 RBC units (90.2% of total) during 2702 red cell exchange (RCE) sessions (median: 14.5 (IQR 1, 47.5) RCE per transfused patient). A median of 7 RBC units (IQR 6, 9) were transfused per RCE session, with a median of 30 days (IQR 28, 40) between sessions.
Discussion
Patients with SCD at our center frequently received O‐negative units, and large RBC volumes were used for RCE. These results provide a utilization baseline for future education and quality improvement initiatives to optimize RBC stewardship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, Alberta, Canada.
- Ottawa Hospital Research Institute, Ottawa Hospital Center for Transfusion, Ottawa, Ontario, Canada.
- Division of Hematology, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Kelsey Uminski
Förderung
- Canadian Hematology Society
Zitieren
APA
Uminski, K., Perelman, I., Mack, J., & Tinmouth, A. (2025). Red blood cell utilization in patients with sickle cell disease: A Canadian single‐center experience. Transfusion. https://doi.org/10.1111/trf.18103
Vancouver
Uminski K, Perelman I, Mack J, Tinmouth A. Red blood cell utilization in patients with sickle cell disease: A Canadian single‐center experience. Transfusion. 2025. doi:10.1111/trf.18103
BibTeX
@article{Uminski2025,
author = {Uminski, Kelsey and Perelman, Iris and Mack, Johnathan and Tinmouth, Alan},
title = {Red blood cell utilization in patients with sickle cell disease: A Canadian single‐center experience},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18103}
}
EUVIMED